Chronic pancreatitis: potential future interventions

References

• Mitchell RMS, Byrne MF, Baillie J. Pancreatitis. Lancet 2003;361:1447–55.
   PubMed Web of Science ®Google Scholar
• Layer P, Tamamanto H, Kalthoff L, Clain JE, Bakken LJ, DiMagno EP. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994;107:1481–7.
   PubMed Web of Science ®Google Scholar
• Bordalo O, Goncalves D, Noronha M, Cristina ML, Salgadinho A, Dreiling DA, Newer concept for the pathogenesis of chronic alcoholic pancreatitis. Am J Gastroenterol 1977;68:278–85.
   PubMed Web of Science ®Google Scholar
• Gullo L, Casadei R, Migliori M, Manca M, Bastagli L, Pezilli R, A search for acute necrotic pancreatitis in early stages of alcoholic chronic pancreatitis. J Clin Gastroenterol 2006;40:435–9.
   PubMed Web of Science ®Google Scholar
• Sarles H, Sarles J-C, Camatte R, Muratore R, Gaini M, Guien C, Observations on 205 confirmed cases of acute pancreatitis, recurring pancreatitis, and chronic pancreatitis. Gut 1965;6:545–58.
   PubMed Web of Science ®Google Scholar
• Payan H, Sarles H, Demirdjian M, Gauthier AP, Cros RC, Durbec JP. Study of the histological features of chronic pancreatitis by correspondence analysis. Identification of chronic calcifying pancreatitis as an entity. Rev Eur Etudes Clin Biol 1973;17:663–70.
   Google Scholar
• Uys CJ, Bank S, Marks IN. The pathology of chronic pancreatitis in Cape Town. Digestion 1973;9:454–68.
   PubMed Web of Science ®Google Scholar
• Gullo L, Costa PL, Labo G. Chronic pancreatitis in Italy: aetiological, clinical and histological observations based on 253 cases. Rendic Gastroenterol 1977;9:97–104.
   Google Scholar
• Sahel J, Cros RC, Durbec JP, Sarles H, Bank S, Marks IN, Multicenter pathological study of chronic pancreatitis: morphological regional variations and differences between chronic calcifying pancreatitis and obstructive pancreatitis. Pancreas 1986;1:471–7.
   PubMedGoogle Scholar
• Migliori M, Manca M, Santini D, Pezilli R, Gullo L. Does acute alcoholic pancreatitis precede the chronic form or is the opposite true? J Clin Gastroenterol 2004;38:272–5.
   PubMed Web of Science ®Google Scholar
• Braganza JM. Pancreatic disease: a casualty of hepatic ‘detoxification’? Lancet 1983;2:1000–3.
   PubMed Web of Science ®Google Scholar
• Sarles H, Bernard JP, Gullo L. Pathogenesis of chronic pancreatitis. Gut 1990;31:629–32.
   PubMed Web of Science ®Google Scholar
• Klöppel G, Maillet B. Pathology of acute and chronic pancreatitis. Pancreas 1993;8:659–70.
   PubMed Web of Science ®Google Scholar
• Comfort MW, Gambill EE, Baggenstoss AH. Chronic relapsing pancreatitis. Gastroenterology 1946;6:239–85.
   PubMed Web of Science ®Google Scholar
• Ammann RW, Heitz PU, Klöppel G. Course of alcoholic chronic pancreatitis: a prospective clinicomorphological longterm study. Gastroenterology 1996;111:224–31.
   PubMed Web of Science ®Google Scholar
• Whitcomb DC. Gene mutations as a cause of chronic pancreatitis. In: Adler G, Amman R, Buchler M, DiMagio EP, Sarner M, Eds. Pancreatitis: Advances in pathobiology, diagnosis and treatment (Falk Symposium 143). Freiburg, Germany, October 14–15, 2004. Lancaster, UK, Springer, 2005, pp 139–52.
   Google Scholar
• Cavallini G. Is chronic pancreatitis a primary disease of the pancreatic ducts? A new pathogenetic hypothesis. Ital J Gastroenterol 1993;25:400–7.
   PubMedGoogle Scholar
• Kulling D, Tresch S, Renner E. Triad of sclerosing cholangitis, chronic pancreatitis, and sjogren's syndrome: Case report and review. Gastrointest Endosc 2003;57:118–20.
   PubMed Web of Science ®Google Scholar
• Montefusco PP, Geiss AC, Bronzo RL, Randall S, Kahn E, McKinley MJ. Sclerosing cholangitis, chronic pancreatitis, and sjogren's syndrome: a syndrome complex. Am J Surg 1984;147:822–6.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Montgomery SM, Ekbom A. Risk of pancreatitis in 14,000 individuals with celiac disease. Clin Gastroenterol Hepatol 2007;5:1347–53.
   PubMed Web of Science ®Google Scholar
• Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732–8.
   PubMed Web of Science ®Google Scholar
• Puig-Divi V, Molero X, Salas A, Guarner F, Guarner L, Malagelada JR. Induction of chronic pancreatic disease by trinitrobenzene sulfonic acid infusion intro rat pancreatic ducts. Pancreas 1996;13:417–24.
   PubMed Web of Science ®Google Scholar
• Hunger RE, Mueller C, Z'Graggen K, Freiss H, Buchler MW. Cytotoxic cells are activated in cellular infiltrates of alcoholic chronic pancreatitis. Gastroenterology 1997;112:1656–63.
   PubMed Web of Science ®Google Scholar
• Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, Menke A, Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998;115:421–32.
   PubMed Web of Science ®Google Scholar
• Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 1998;43:128–33.
   PubMed Web of Science ®Google Scholar
• Tahara J, Shimizu K, Shiratori K. Engulfment of necrotic acinar cells by pancreatic stellate cells inhibits pancreatic fibrogenesis. Pancreas 2008;37:69–74.
   PubMed Web of Science ®Google Scholar
• Shimizu K, Kobayashi M, Tahara J, Shiratori K. Cytokines and peroxisome proliferator-activated receptor gamma ligand regulate phagocytosis by pancreatic stellate cells. Gastroenterology 2005;128:2105–18.
   PubMed Web of Science ®Google Scholar
• Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002;298:911–12.
   Web of Science ®Google Scholar
• Tasci I, Deveci S, Isik AT, Comert B, Akay C, Mas N, Allopurinol in rat chronic pancreatitis: effects on pancreatic stellate cell activation. Pancreas 2007;35:366–71.
   PubMed Web of Science ®Google Scholar
• Masamune A, Shimosegawa T. Signal transduction in pancreatic stellate cells. J Gastroenterol 2009;44:249–60.
   PubMed Web of Science ®Google Scholar
• McCarroll JA, Phillips PA, Santucci N, Pirola RC, Wilson JS, Apte MV. Vitamin A inhibits pancreatic stellate cell activation: implications for treatment of pancreatic fibrosis. Gut 2006;55:79–89.
   PubMed Web of Science ®Google Scholar
• Gomez JA, Molero X, Vaquero E, Alonso A, Salas A, Malagelada JR. Vitamin E attenuates biochemical and morphological features associated with development of chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol 2004;287:G162–9.
   Web of Science ®Google Scholar
• Rickmann M, Vaquero EC, Malagelada JR, Molero X. Tocotrienols induce apoptosis and autophagy in rat pancreatic stellate cells through the mitochondrial death pathway. Gastroenterology 2007;132:2518–32.
   PubMed Web of Science ®Google Scholar
• Yoo BM, Oh TY, Kim YB, Yeo M, Lee JS, Surth YJ, Novel antioxidant ameliorates the fibrosis and inflammation of cerulein-induced chronic pancreatitis in a mouse model. Pancreatology 2005;5:165–76.
   PubMed Web of Science ®Google Scholar
• Masamue A, Kikuta K, Satoh M, Suzuki N, Shimosegawa T. Green tea polyphenol epigallocatechin-3-gallate blocks PDGF-induced proliferation and migration of rat pancreatic stellate cells. World J Gastroenterol 2005;11:3368–74.
   PubMed Web of Science ®Google Scholar
• Masamune A, Watanabe T, Kikuta, Satoh K, Shimosegawa T. NADPH oxidase plays a crucial role in the activation of pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2008;294:G99–108.
   PubMed Web of Science ®Google Scholar
• Mohseni Salehi Monfared SS, Vahidi H, Abdolghaffari AH, Nikfar S, Abdollahi M. Antioxidant therapy in the management of acute, chronic and post-ERCP pancreatitis: a systematic review. World J Gastroenterol 2009;15:4481–90.
   PubMed Web of Science ®Google Scholar
• Zion O, Genin O, Kawada N, Yoshizato K, Roffe S, Nagler A, Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention. Pancreas 2009;38:427–35.
   PubMed Web of Science ®Google Scholar
• Jaster R, Sparmann G, Emmrich J, Liebe S. Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells. Gut 2002;51:579–84.
   PubMed Web of Science ®Google Scholar
• Masamune A, Satoh A, Kikuta K, Sakai Y, Satoh A, Shimosegawa T. Inhibition of p38 mitogen-activated protein kinase blocks activation of rat pancreatic stellate cells. J Pharmacol Exp Ther 2003;304:8–14.
   PubMed Web of Science ®Google Scholar
• Baumert JT, Sparmann G, Emmrich J, Liebe S, Jaster R. Inhibitory effect of interferons on pancreatic stellate cell activation. World J Gastroenterol 2006;12:896–901.
   PubMed Web of Science ®Google Scholar
• Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 1977;57:313–70.
   PubMed Web of Science ®Google Scholar
• Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006;86:747–803.
   PubMed Web of Science ®Google Scholar
• Tsang SW, Ip SP, Leung PS. Prophylactic and therapeutic treatments with AT 1 and AT 2 receptor antagonists and their effects on changes in the severity of pancreatitis. Int J Biochem Cell Biol 2004;36:330–9.
   PubMed Web of Science ®Google Scholar
• Yamada T, Kuno A, Masuda K, Ogawa K, Sogawa M, Nakamura S, Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats. J Pharmacol Exp Ther 2003;307:17–23.
   PubMed Web of Science ®Google Scholar
• Nagashio Y, Asaumi H, Watanabe S, Nomiyama Y, Taguchi M, Tashiro M, Angiotensin II type 1 receptor interaction is an important regulator for the development of pancreatic fibrosis in mice. Am J Physiol Gastrointest Liver Physiol 2004;287:G170–7.
   Web of Science ®Google Scholar
• Ulmasov B, Xu Z, Tetri LH, Inagami T, Neuschwander-Tetri BA. Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis. Am J Physiol Gastrointest Liver Physiol 2009;296:G284–94.
   PubMed Web of Science ®Google Scholar
• Tsang SW, Ip SP, Wong TP, Che CT, Leung PS. Differential effects of saralasin and ramiprilat, the inhibitors of renin-angiotensin system, on cerulein-induced acute pancreatitis. Regul Pept 2003;111:47–53.
   PubMedGoogle Scholar
• Kuno A, Yamada T, Masuda K, Ogawa K, Sogawa M, Nakamura S, Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male wistar bonn/kobori rats. Gastroenterology 2003;124:1010–19.
   PubMed Web of Science ®Google Scholar
• van Westerloo DJ, Florquin S, de Boer AM, Daalhuisen J, de Vos AF, Bruno MJ, Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice. Am J Pathol 2005;166:721–8.
   PubMed Web of Science ®Google Scholar
• Jaster R, Brock P, Sparmann G, Emmrich J, Liebe S. Inhibition of pancreatic stellate cell activation by the hydroxymethylglutaryl coenzyme A reductase inhibitor lovastatin. Biochem Pharmacol 2003;65:1295–303.
   PubMed Web of Science ®Google Scholar
• Casey PJ, Solski PA, Der CJ, Buss JE. P21ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci USA 1989;86:8323–37.
   PubMed Web of Science ®Google Scholar
• Gibo J, Ito T, Kawabe K, Hisano T, Inoue M, Fujimori N, Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cell activity. Lab Invest 2005;85:75–89.
   PubMed Web of Science ®Google Scholar
• Su SB, Motoo Y, Xie MJ, Sakai J, Taga H, Sawabu N. Expression of pancreatitis associated protein (PAP) in rat spontaneous chronic pancreatitis: effect of the herbal medicine Saiko-keishi-to (Tj-10). Pancreas 1999;19:239–47.
   PubMed Web of Science ®Google Scholar
• Su SB, Motoo Y, Xie MJ, Taga H, Sawabu N. Antifibrotic effect of herbal medicine Saiko-keishi-to (TJ 10) on chronic pancreatitis in WBN/Kob rat. Pancreas 2001;22:8–17.
   PubMed Web of Science ®Google Scholar
• Masamune A, Suzuki N, Kikuta K, Satoh M, Satoh K, Shimosewaga T. Curcumin blocks activation of pancreatic stellate cells. J Cell Biochem 2006;95:1080–93.
   Google Scholar
• Suzuki N, Masamune A, Kikuta K, Watanabe T, Satoh K, Shimosegawa T. Ellagic acid inhibits pancreatic fibrosis in male Wistar Bonn/Konori rats. Dig Dis Sci 2009;54:802–10.
   PubMed Web of Science ®Google Scholar